Document:

EX-10.13

 Exhibit 10.13 

ARGO MEDICAL TECHNOLOGIES LTD. 

2012 ISRAELI EQUITY INCENTIVE SUB PLAN 
  

	I.	GENERAL 

 This 2012 Israeli Equity Incentive Sub Plan (the “Sub-Plan”) is a sub plan to
the 2012 Equity Incentive Plan (the “Plan”) of Argo Medical Technologies Ltd. (the “Company”) and set forth the terms for the grant of Awards to Israeli Employee or Israeli Non-Employee (as defined below). 

 

	II.	DEFINITIONS 

 1. Any capitalized term not specifically defined in this Sub-Plan shall
have the meaning assigned to it in the Plan. 
 2. As used in this Sub-Plan, the following definitions shall apply: 

“Affiliate” means an affiliate of, or person affiliated with, a specified person or company or other trade or business that
directly, or indirectly through one or more intermediaries, controls, is controlled by or is under common control with such person within the meaning of Rule 405 of Regulation C under the Securities Act, including, without limitation, any Parent or
Subsidiary. For the purpose of Awards granted pursuant to Section 102 shall mean also an “employing company” within the meaning of Section 102(a) of the Ordinance. 

“Capital Gain Option” means a Trustee 102 Option intended to qualify under the capital gain tax treatment in accordance with
the provisions of Section 102(b)(2) of the Ordinance. 
 “Capital Gain Share” means a Trustee 102 Share intended to
qualify under the capital gain tax treatment in accordance with the provisions of Section 102(b)(2) of the Ordinance. 

“Capital Gain Award” means Options granted under this Sub-Plan as Capital Gain Option and/or Shares granted under this
Sub-Plan as Capital Gain Shares and/or Awards granted under this Sub-Plan intended to qualify under the capital gain tax treatment in accordance with the provisions of Section 102(b)(2) of the Ordinance. 

“Controlling Shareholder” shall have the meaning ascribed to it in Section 32(9) of the Ordinance as amended from time
to time. 
 “Israeli Employee” means any employee of the Company or its Affiliate, and any individual who is serving as
Nosei Misra - Officer Holder (as such term is defined in the Israeli Companies’ Law, 5759-1999, including directors) of the Company or its Affiliate, but excluding any Controlling Shareholder. 

“Israeli Non-Employee” means any individual or an entity providing services to the Company or its Affiliate who is not an
Israeli Employee. 

 “ITA” means the Israeli Tax Authority. 

“Non Trustee 102 Option” means an Option granted to an Israeli Employee pursuant to Section 102(c) of the Ordinance and
not held in trust by a Trustee. 
 “Non Trustee 102 Share” means Shares granted to an Israeli Employee pursuant to
Section 102(c) of the Ordinance and not held in trust by a Trustee. 
 “Non Trustee Award” means Options granted under
this Sub-Plan as Non Trustee 102 Options and Shares granted under this Sub-Plan as Non Trustee 102 Shares and Awards granted pursuant to Section 102(c) of the Ordinance. 

“3(i) Option” means an Option granted pursuant to Section 3(i) of the Ordinance. 

“Option” means an option to purchase Shares of the Company granted pursuant to Section 3(i) and/or Section 102 of
the Ordinance. 
 “Ordinance” means the Income Tax Ordinance [New Version], 5721, 1961 as now in effect or as hereafter
amended. 
 “Ordinary Income Option” means a Trustee 102 Option intended to qualify under the ordinary income tax treatment
in accordance with the provisions of Section 102(b)(1) of the Ordinance. 
 “Ordinary Income Share” means a Trustee
102 Share intended to qualify under the ordinary income tax treatment in accordance with the provisions of Section 102(b)(1) of the Ordinance. 

“Ordinary Income Award” means Options granted under this Sub-Plan as Ordinary Income Option and shares granted under this
Sub-Plan as Ordinary Income Shares and Awards granted pursuant to Section 102(b)(1) of the Ordinance. 
 “Section 102”
means Section 102 of the Ordinance and any regulations, rules, orders or procedures promulgated thereunder as now in effect or as hereafter amended. 

“Award Agreement” means a written agreement between the Company and a holder of anAward evidencing the terms and conditions
of an individual Award grant. Each Award Agreement shall be subject to the terms and conditions of the Plan and this Sub-Plan. 

“Trustee” means any individual or entity appointed by the Company to serve as a trustee and approved by the ITA, all in
accordance with the provisions of Section 102(a) of the Ordinance and the regulations thereof. 
 “Trustee 102 Option”
means an Option granted pursuant to Section 102(b) of the Ordinance and held in trust by a Trustee for the benefit of an Israeli Employee. 

“Trustee 102 Share” means Shares granted pursuant to Section 102(b) of the Ordinance and held in trust by a Trustee for
the benefit of an Israeli Employee. 

  
 2 

 “Trustee 102 Award” means Options granted under this Sub-Plan as Trustee 102
Option and/or shares granted under this Sub-Plan as Trustee 102 Shares and/or Awards granted pursuant to Section 102(b) of the Ordinance. 
  

	III.	OPTION GRANTS AND SHARE GRANTS 

 Eligibility. The persons eligible to receive
Awards under this Sub-Plan are Israeli Employees and/or Israeli Non-Employees. 
 Types of Options. The Board shall have the
authority to grant an Option under this Sub-Plan classified as (i) a Trustee 102 Option, (ii) a Non Trustee 102 Option or (iii) a 3(i) Option; provided, however, that a Trustee 102 Option and a Non Trustee 102 Option may
only be granted to an Israeli Employee, and a 3(i) Option shall be granted only to an Israeli Non Employee. 
 Types of Shares. The
Board shall have the authority to grant shares under this Sub-Plan classified as (i) a Trustee 102 Share, or (ii) a Non Trustee 102 Share; provided, however, that a Trustee 102 Share and a Non Trustee 102 Share shall only be
granted to an Israeli Employee. 
 Trustee 102 Award. 

(a) The grant of Trustee 102 Award under this Sub-Plan shall be conditioned upon the approval of this Sub-Plan and the Trustee by the ITA, and
the filing of the Company’s Election (as defined below) with the ITA at least thirty (30) days before the first date of grant of Awards under this Sub-Plan. The grant of 102 Trustee Award shall be in accordance with the terms and
conditions of Section 102. 
 (b) The Company may grant at any single time only one type of Trustee 102 Award, either Capital Gain
Award or Ordinary Income Award (the “Election”). The Company shall file its Election with the ITA. The Election shall apply to any Employee who has been granted Trustee 102 Award. The first Election shall become effective as of the
date of grant of the first Trustee 102 Award granted under this Sub-Plan and shall remain in effect at least until the end of the year following the year during which the Company first granted Trustee 102 Award. The Company may not be entitled to
change its election at least until the lapse of a year from the end of the year in which the first Trustee 102 Award were granted pursuant to the prior Election. 

(c) Such Election shall not prevent the Company from granting Non Trustee 102 Award to Israeli Employees or 3(i) Options to Israeli
Non-Employees simultaneously. 
 (d) All Trustee 102 Award will be held in trust by a Trustee, as described in Section IV below. 

Non Trustee 102 Award. The granting of a Non Trustee 102 Award to an Israeli Employee shall be made in accordance with the provisions
of Section 102(c) of the Ordinance. With respect to Non Trustee 102 Award or other Share Awards which are deemed as Non Trustee 102 Award, in the event of termination of Israeli Employee’s engagement with the Company or any of its
Affiliate, then the Israeli Employee shall extend to the Company and/or its Affiliate a security or guarantee for the payment of tax and/or social charges due at the time of sale of Non Trustee 102 Award, all in accordance with the provisions of
Section 102. 

  
 3 

 3(i) Option. The Company may grant 3(i) Option to any person who is an Israeli Non
Employee. 
  

	IV.	TRUSTEE 

 Appointment of Trustee. A Trustee shall be appointed by the Board to
administer each Trustee 102 Award in accordance with the provisions of Section 102 and pursuant to a written agreement to be entered into between the Trustee and the Company (the “Trust Agreement”). 

Grants of Trustee 102 Award. All Trustee 102 Award granted under this Sub-Plan as well as shares allocated or issued upon exercise of
such Trustee 102 Award and/or bonus shares and/or any rights granted with respect to such Trustee 102 Award, shall be registered and held by the Trustee for the benefit of the Israeli Employee for the requisite period of time as required by
Section 102 or any regulations, rules or orders or procedures promulgated thereunder (the “Holding Period”), The Trustee shall be exempt from any liability in respect of any action or decision duly taken in its capacity as a
Trustee, provided, however, that the Trustee acted at all times in good faith. 
 Grants of 3(i)Option. The Board may
choose to deposit the 3(i) Option with the Trustee. In such event, the Trustee shall hold such 3(i) Option in trust, until exercised by the Participant, pursuant to the Company’s instructions from time to time. 

Release of Awards. The Trustee shall not release any Trustee 102 Award granted under this Sub-Plan as well as shares allocated or
issued upon exercise of such Trustee 102 Award and/or bonus shares and/or any rights granted with respect to such Trustee 102 Award, until all required payments have been fully made: (i) the receipt by the Trustee of an acknowledgment from the
ITA that the Israeli Employee has paid any applicable tax due pursuant to the Ordinance, or (ii) the Company has made other arrangements for the deduction of tax at source acceptable to the Trustee. 

 

	V.	THE HOLDING PERIOD REQUIREMENT 

 Holding Period Requirements. 

(a) Trustee 102 Award may not be sold, transferred, assigned, pledged, given as collateral, or mortgaged (other than through a transfer by
will or by operation of law), nor may they be subject of an attachment, seizure power of attorney or transfer deed unless Section 102 and/or the regulations, rules, orders or procedures promulgated thereunder allow otherwise. 

(b) With respect to any Awards granted as Trustee 102 Award, and subject to the provisions of Section 102, an Israeli Employee shall not
be entitled to sell or release from trust any Trustee 102 Award, Share received upon the exercise of any such Trustee 102 Option and/or bonus shares granted with respect to such Trustee 102 Award, until the lapse of the Holding Period and in
accordance with Section 102. Notwithstanding the above, if any such sale or 

  
 4 

 
release occurs during the Holding Period it will result in adverse tax consequences to the Israeli Employee under Section 102 of the Ordinance and the Rules, which shall apply to and shall
be borne solely by such Israeli Employee. 
 Trustee 102 Award Requirements. In the event that the requirements of Section 102
with respect to Trustee 102 Award are not met, then it shall be treated in accordance with the provisions of Section 102 and any regulations promulgated thereunder. 

Award Agreement. Upon receipt of Trustee 102 Award, Israeli Employee shall sign an Award Agreement under which the Israeli Employee
shall, among others, (i) agree to be subject to the trust agreement between the Company and the Trustee, stating, among others, that the Trustee will be released from any liability in respect of any action or decision duly taken and bona fide
executed in relation with the Plan, or any Awards granted to him or her thereunder; (ii) declare that he/she understands the provisions of Section 102 and the applicable tax track and approve the tax arrangement; and (iii) confirm
that he/she shall not sell nor transfer the Awards from the Trustee until the lapse of the Holding Period. 
  

	VI.	DIVIDEND 

 Any dividends payable with respect to shares acquired upon exercise of an
Option or an Award or shares issued under the Sub-Plan and the Plan shall also be subject to the provisions of Section 102 and the rules, regulations or orders promulgated thereunder. 

 

	VII.	TAX CONSEQUENCES 

 Israeli Employee. 

(a) Any tax consequences (including, without limitation, the Israeli Employee’s social security taxes and health insurance, if
applicable) arising from the grant vesting or exercise of any Award and/or Option or from sale or release or transfer of such Option or shares or from any other event or act (of the Company and/or its Affiliate, the Trustee or the Israeli Employee)
shall be borne solely by the Israeli Employee. Notwithstanding the foregoing, the Company and/or its Affiliate and/or the Trustee shall withhold taxes according to the requirements under the laws, rules, and regulations, including withholding taxes
at source under Section 102. 
 (b) Furthermore, the Participant shall indemnify the Company and/or Affiliate and/or the Trustee,
and/or the Company’s shareholders and/or directors and/or officers if applicable, and hold them harmless against and from any and all liability for any such tax or interest or penalty thereon, including without limitation, liabilities relating
to the necessity to withhold, or to have withheld, any such tax from any payment made to the Israeli Employee. 
 (c) The Company shall not
be obligated to honor the exercise of any Option by or on behalf of a Participant until all tax consequences (if any) arising from the grant of an Award and/or exercise of Options and/or sale of shares and/or Awards are resolved to the full
satisfaction of the Company. Without derogating from the above, the Company and/or the Trustee when applicable shall not be required to release any share certificate until all required payments (including tax payments) have been fully made in
accordance with Section 102 and/or the lTO. 

  
 5 

 (d) If at the date of grant the Company’s shares (or options) are listed on any established
stock exchange or a national market system or if the Company’s shares (or option) will be registered for trading within ninety (90) days following the date of grant, the fair market value and classification of income as either capital gain
or ordinary income shall be determined pursuant to Section 102(b)(3) of the Ordinance. Without derogating from the definition of “Fair Market Value” in the Plan and solely for the purpose of determining the tax liability pursuant to
Section 102(b)(3) of the Ordinance, if at the date of grant the Company’s shares are listed on any established stock exchange or a national market system or if the Company’s shares will be registered for trading within ninety
(90) days following the date of grant of the Capital Gain Options, subject to applicable law, the fair market value of the shares at the date of grant shall be determined in accordance with the average value of the Company’s shares on the
thirty (30) trading days preceding the date of grant or on the thirty (30) trading days following the date of registration for trading, as the case may be and all in accordance with Section 102(b)(3) of the Ordinance or any tax ruling
obtained from the Israeli tax authority. 
 Israeli Non Employee. Any tax consequences arising from the grant or exercise of any
Option and/or Award, or from sale or transfer of such Award or from any other event or act (of the Company and/or its Affiliate or the Israeli Non Employee), hereunder shall be borne solely by the Israeli Non Employee. 

 

	VIII.	COORDINATION WITH THE PLAN 

 Section 102 and any regulations, rules, orders or
procedures promulgated thereunder as now in effect or as hereafter amended shall apply to grant of Awards under the provisions of the Sub-Plan to an Israeli Employee. 

The Plan is hereby incorporated by reference and shall be deemed as anintegral part of this Sub-Plan. Without derogating from the provisions
of Section 102 of the Ordinance, all the terms and conditions of the Plan shall apply to grant of Awards to Israeli Employee or Israeli Non-Employee. In the event of conflict between the Sub-Plan and the Plan the Sub-Plan would take precedence
as for the provisions with respect to Section 102 of the Ordinance. 

  
 6EX-10.14

 Exhibit 10.14 

ARGO MEDICAL TECHNOLOGIES LTD. 

(the “Company”) 

2012 EQUITY INCENTIVE PLAN 

2012 U.S. SUB PLAN 

(For U.S. Participants Only) 
  

	1.	Special Provisions for U.S. Participants  

 This U.S. Sub Plan (the “U.S. Sub
Plan”) to the Company’s 2012 Equity Incentive Plan (the “Plan”) shall apply only to Participants who are citizens or residents of the United States as of the date of the grant of Awards (“U.S.
Participants”). This U.S. Sub Plan shall be deemed to be part of the Plan and all of the provisions of the Plan shall apply to this U.S. Sub Plan, and where any terms of this U.S. Sub Plan are in conflict with the Plan, the terms of the
Plan shall control. 
 Capitalized terms contained herein shall have the same meanings given to them in the Plan, unless otherwise provided by this U.S. Sub
Plan. Notwithstanding any provisions contained in the Plan to the contrary and to the extent required by applicable laws, the following terms shall apply to all Awards granted to U.S. Participants. 

This Sub Plan applies to the grants of any Awards of the Company under the Plan. The purpose of this U.S. Sub Plan is to establish certain rules and
limitations applicable to Awards that may be granted or issued under the Plan from time to time, in compliance with the United States federal income taxation applicable laws currently in force in the United States. Except as otherwise provided by
this Sub Plan, all grants made pursuant to this Sub Plan shall be governed by the terms of the Plan. 
  

	2.	Definitions 

 Capitalized terms not otherwise defined herein shall have the meaning assigned to
them in the Plan. The following additional definitions will apply to grants made pursuant to this Sub Plan: 
 “Exchange Act” means the
Securities Exchange Act of 1934, as amended. 
 “Incentive Share Option” means any Opiton granted to a U.S. Participant intended to be, and
designated as, an “Incentive Stock Option” within the meaning of Section 422 of the Code. 
 “Listing Date” means the first
date upon which any security of the Company is listed (or approved for listing) upon notice of issuance on any securities exchange or designated (or approved for designation) upon notice of issuance as a national market security on an inter dealer
quotation system if such securities exchange or inter dealer quotation system has been certified. 
 “Non-Qualified Share Option” means any
Option granted to a U.S. Participant that is not an Incentive Share Option. 
 “Ten Percent Shareholder” means a person who owns (or is
deemed to own pursuant to Section 424(d) of the Code) shares possessing more than ten percent (10%) of the total combined voting power of all classes of shares of the Company or of any of its Affiliates. 

	 	3.	Eligibility 

 The Board (or to the extent permitted under applicable law, the
Committee) may at any time and from time to time grant Options to U.S. Participants under this Sub-Plan; provided, however, that Incentive Share Option may be granted only to employees in accordance with the Code. 

 

	 	4.	U.S. Award Provisions  

 Each Award shall be in such form and shall contain such terms and
conditions as the Board shall deem appropriate and set forth in the Agreement. All Awards shall be separately designated Incentive Share Options or Nonstatutory Share Options at the time of grant, and, if certificates are issued, a separate
certificate or certificates will be issued for shares purchased on exercise of each type of Award. Any Award granted under this Sub Plan will be in such form as the Board may at the time of such grant approve. 

The Award Agreement evidencing any Award(s) will incorporate, among others, the following terms and conditions and will contain such additional terms and
conditions, as the Board deems appropriate in its sole and absolute discretion: 
 (a) Award Exercise Price. (i) The
Exercise Price per Award will be determined by the Board, subject to applicable law, and will not be less than 100% of the Fair Market Value per Share on the date of the grant. However, a Ten Percent Shareholder shall not be granted an Incentive
Share Option unless the exercise price of such Option is at least one hundred ten percent (110%) of the Fair Market Value of the shares on the date of grant. (ii) Prior to the Listing Date, a Ten Percent Shareholder shall not be granted a
Non-Qualified Share Option unless the exercise price of such Option is at least one hundred ten percent (110%) of the Fair Market Value per Share on the date of grant. 
  

	 	5.	Amendments and Termination 

 (a) The Board shall have the authority to amend this
Sub Plan in accordance with Section 17 of the Plan. 
 (b) The Board may amend, alter or discontinue this Sub-Plan at any time,
provided that no amendment, alteration or discontinuation will be made without the approval of such amendment by the Company’s shares holders and in a manner consistent with the requirements of Section 422 of the Code. 

 

	 	6.	General Provisions 

 (a) The Board may require each U.S. Participant to represent
to, and agree with the Company in writing that, the U.S. Participant is acquiring securities of the Company for investment purposes and without a view to distribution thereof and as to such other matters as the Board believes are appropriate. 

(b) Shares shall not be issued hereunder unless, in the judgment of counsel for the Company, the issuance complies with the requirements of
any stock exchange or quotation system on which the Shares are then listed or quoted, the Securities Act of 1933, the Exchange Act, the Code, all rules and regulations promulgated thereunder and all other applicable laws. 

 (c) All certificates for Shares or other securities delivered under this Sub-Plan will be subject
to such transfer orders and other restrictions as the Board may deem advisable under the rules, regulations, and other requirements of any stock exchange upon which the shares are then listed and any applicable laws, and the Board may cause a legend
or legends to be put on any such certificates to make appropriate reference to such restrictions. 
 (d) No later than the date as of which
an amount first becomes includible in the gross income of the U.S. Participant for United States federal income tax purposes with respect to any Award, the U.S. Participant will pay to the Company, or make arrangements satisfactory to the Board
regarding the payment of taxes of any kind required by law to be withheld with respect to such amount. The obligations of the Company under the Plan and this Sub Plan will be conditioned on such payment or arrangements and the Company will have the
right to deduct any such taxes from any payment of any kind otherwise due to the U.S. Participant. Unless otherwise determined by the Board, the minimum required withholding obligation with respect to an Award may be settled in shares of Company,
including the Shares that are subject to that Award. 
  

	 	7.	California Participants. 

 A U.S. Participant located in California shall receive Nonqualified
Share Options and Incentive Share Options that comply also with the California Award Terms and Conditions attached as Appendix A. 
  

	 	8.	Invalid Provisions 

 In the event that any provision of this Sub-Plan is found to be invalid or
otherwise unenforceable under any applicable law, such invalidity or unenforceability will not be construed as rendering any other provisions contained herein as invalid or unenforceable, and all such other provisions will be given full force and
effect to the same extent as though the invalid or unenforceable provision was not contained herein. 

****************************************************************************** 

 APPENDIX A 

ARGO MEDICAL TECHNOLOGIES LTD. 

CALIFORNIA AWARD TERMS AND CONDITIONS 

(Applicable to U.S. Participants Located in California) 

Definitions. With respect to U.S. Participants located in California (“Participant”), the following terms shall have the respective
meanings set forth below: 
 “California Code” means the California Corporate Securities Law of 1968, as amended. 

“California Regulations” means the regulations set forth in Title 10 of the California Code of Regulations. 

“Disability” means (x) before the Listing Date, the inability of a Participant, in the opinion of a qualified physician
acceptable to the Company, to perform the major duties of the Participant’s position with the Company or any Affiliate because of the sickness or injury of the Participant, and (y) after the Listing Date, the permanent and total disability
of a Participant within the meaning of Section 22(e)(3) of the Code. 
 Applicability of this Annex A. Prior to the Listing Date, unless an
applicable exemption from Section 25110 of the California Code other than the exemption set forth in Section 25102(o) of the California Code is available, Awards granted under this Plan that are subject to the California Code shall be
subject to the additional requirements of this Annex A. In the event of any conflict or inconsistency between the provisions of this Annex A and the Plan and/or the U.S. Sub Plan, the provisions of this Appendix A shall control. 

Securities Law Compliance. Prior to the Listing Date, a person shall not be eligible for the grant of an Award if, at the time of grant, either the
offer or the sale of the Company’s securities to such person is not exempt under Rule 701 of the Securities Act because of the nature of the services that the person is providing to the Company and/or any Affiliate, or because such person is
not a natural person, or as otherwise provided by Rule 701, unless the Company determines that such grant need not comply with the requirements of Rule 701 and will satisfy another exemption under the Securities Act as well as comply with the
securities laws of all other relevant jurisdictions. 
 Termination of Employment. In the event a Participant’s employment terminates (other
than upon the Participant’s death or Disability), the Participant may exercise the Participant’s Award (to the extent that the Participant was entitled to exercise such Award as of the date of termination or as otherwise permitted by the
Committee) but only within such period of time ending on the earlier of (i) the date thirty (30) days following the Participant’s severance date (or such longer specified in the Award Agreement) or (ii) the expiration of the term
of the Award as set forth in the Award Agreement. If, after termination, the Participant does not exercise the Participant’s Award within the time specified in the Award Agreement, the Award shall terminate. 

 Disability of Participant. In the event that a Participant’s employment terminates as a result of the
Participant’s disability, the Participant may exercise the Participant’s Award (to the extent that the Participant was entitled to exercise such Award as of the date of termination), but only within such period of time ending on the
earlier of (i) the date six (6) months following the Participant’s severance date (or such longer period specified in the Award Agreement ) or (ii) the expiration of the term of the Award as set forth in the Award Agreement. If,
after termination, the Participant does not exercise the Participant’s Award within the time specified herein, the Award shall terminate. 
 Death
of Participant. In the event (i) a Participant’s employment terminates as a result of the Participant’s death or (ii) the Participant dies within the period (if any) specified in the Award after the termination of the
Participant’s employment for a reason other than death, then the Award may be exercised (to the extent the Participant was entitled to exercise such Award as of the date of death or as otherwise permitted by the Committee) by the
Participant’s estate, by a person who acquired the right to exercise the Award by bequest or inheritance or by a person designated to exercise the Award upon the Participant’s death, but only within the period ending on the earlier of
(x) the date six (6) months following the date of death (or such longer or shorter period specified in the Award Agreement) or (y) the expiration of the term of such Award as set forth in the Award Agreement. If, after death, the
Award is not exercised within the time specified herein, the Award shall terminate. 
 Filing with California Commissioner of Corporations. No
later than thirty (30) days after an Award subject to this Appendix A is granted under the Plan and/or the U.S. Sub Plan, the Company shall file a notice of transaction in accordance with rules adopted by the California Commissioner of
Corporations, accompanied by a filing fee as prescribed by subdivision (y) of Section 25608 of the California Code, or any successor provision thereto. 

******************************************************************************

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00233-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00233-of-00352.parquet"}]]